グローバルワクチン市場動向(~2020)...市場調査レポートについてご紹介

【英文タイトル】Global Vaccine Market Outlook 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Analyst View
2. Research Methodology
3. Global Vaccine Market Outlook to 2020
4. Major Vaccines: Current and Future Market Analysis
4.1 Pneumococcal
4.2 Influenza
4.3 Cancer
4.4 Polio
4.5 Varicella
4.6 Rotavirus
4.7 Meningococcal
4.8 DTP
4.9 Hepatitis
4.10 Measles, Mumps, and Rubella (MMR)
4.11 Japanese Encephalitis
4.12 Tuberculosis
4.13 Malaria
4.14 Rabies
4.15 Typhoid
4.16 HIV
5. Key Geographical Markets
5.1 US
5.2 Europe
5.3 Japan
5.4 China
5.5 India
5.6 Brazil
6. Pipeline Analysis
7. Competitive Landscape
7.1 GSK
7.1.1 Business Overview
7.1.2 Vaccine Portfolio & Pipeline
7.1.3 Strengths and Weaknesses
7.2 Sanofi-Pasteur
7.2.1 Business Overview
7.2.2 Vaccine Portfolio & Pipeline
7.2.3 Strengths and Weaknesses
7.3 Pfizer
7.3.1 Business Overview
7.3.2 Vaccine Portfolio & Pipeline
7.3.3 Strengths and Weaknesses
7.4 Merck
7.4.1 Business Overview
7.4.2 Vaccine Portfolio & Pipeline
7.4.3 Strengths and Weaknesses
7.5 Novartis
7.5.1 Business Overview
7.5.2 Vaccine Portfolio & Pipeline
7.5.3 Strengths and Weaknesses
7.6 Emergent Biosolutions
7.6.1 Business Overview
7.6.2 Vaccine Portfolio & Pipeline
7.6.3 Strengths and Weaknesses
7.7 AstraZeneca Plc.
7.7.1 Business Overview
7.7.2 Vaccine Portfolio & Pipeline
7.7.3 Strengths and Weaknesses
7.8 Baxter International Inc.
7.8.1 Business Overview
7.8.2 Vaccine Portfolio & Pipeline
7.8.3 Strengths and Weaknesses
7.9 BioCSL (CSL Biotherapies)
7.9.1 Business Overview
7.9.2 Vaccine Portfolio & Pipeline
7.9.3 Strengths and Weaknesses
7.10 Dendreon Corporation
7.10.1 Business Overview
7.10.2 Vaccine Portfolio & Pipeline
7.10.3 Strengths and Weaknesses
7.11 Takeda Pharmaceutical Company Limited
7.11.1 Business Overview
7.11.2 Vaccine Portfolio & Pipeline
7.11.3 Strengths and Weaknesses
7.12 Crucell
7.12.1 Business Overview
7.12.2 Vaccine Portfolio & Pipeline
7.12.3 Strengths and Weaknesses

List of Figures:

Figure 3-1: Global – Vaccine Market (Billion US$), 2013-2020
Figure 4-1: Global – Causes of Deaths in Children (<5 Years) among Low-income Countries (%), 2011 Figure 4-2: Global – Pneumococcal Vaccine Market (Billion US$), 2013-2020 Figure 4-3: Global – Influenza Vaccine Market (Billion US$), 2013-2020 Figure 4-4: Global – Cancer Vaccine Market (Billion US$), 2013-2020 Figure 4-5: Global – Polio Vaccine Market (Billion US$), 2013-2020 Figure 4-6: Global – Varicella Vaccine Market (Billion US$), 2013-2020 Figure 4-7: Global – Rotavirus Vaccine Market (Billion US$), 2013-2020 Figure 4-8: Global – Meningococcal Vaccine Market (Billion US$), 2013-2020 Figure 4-9: Global – Number of Diphtheria Incidences by Region (2009 & 2010) Figure 4-10: Global – Number of nTetanus Incidences by Region (2009 & 2010) Figure 4-11: Global – Number of tTetanus Incidences by Region (2009 & 2010) Figure 4-12: Global – Number of Pertussis Incidences by Region (2009 & 2010) Figure 4-13: Global – DTP Vaccine Market (Billion US$), 2013-2020 Figure 4-14: Global – Hepatitis Vaccine Market (Billion US$), 2013-2020 Figure 4-15: Global – Number of Measles Incidences by Region (2009 & 2010) Figure 4-16: Global – Number of Mumps Incidences by Region (‘000), 2009 & 2010 Figure 4-17: Global – Number of Rubella Incidences by Region (2009 & 2010) Figure 4-18: Global – MMR Vaccine Market (Million US$), 2013-2020 Figure 4-19: Global – Japanese Encephalitis Market (Million US$), 2013-2020 Figure 4-20: Global – Sources for Funding in HIV Vaccine R&D (%), 2011 Figure 5-1: Global – Vaccine Market by Region (%), 2013 Figure 5-2: Global – Vaccine Market by Region (%), 2020 Figure 5-3: US – Vaccine Market (Billion US$), 2013-2020 Figure 5-4: Europe – Vaccine Market (Billion US$), 2013-2020 Figure 5-5: Japan – Vaccine Market (Billion US$), 2013-2020 Figure 5-6: China – Vaccine Market (Billion US$), 2013-2020 Figure 5-7: India – Share of Domestic Consumption and Exports in Vaccine Market (2013) Figure 5-8: India – Vaccine Market (Billion US$), 2013-2020 Figure 5-9: Brazil – Vaccine Market (Billion US$), 2013-2020 Figure 7-1: Global – Share of Key Players in Vaccine Market (2013) Figure 7-2: GSK – Revenue Breakup by Business Segment (%), 2013 Figure 7-3: GSK – Vaccine Revenue Breakup by Product (%), 2013 Figure 7-4: Sanofi-Pasteur – Revenue Breakup by Business Segment (%), 2013 Figure 7-5: Sanofi-Pasteur – Vaccine Revenue Breakup by Product (%), 2013 Figure 7-6: Pfizer – Revenue Breakup by Business Segment (%), 2013 Figure 7-7: Pfizer – Revenue Breakup by Biopharmaceuticals (%), 2013 Figure 7-8: Merck – Revenue Breakup by Business Segment (%), 2013 Figure 7-9: Merck – Pharmaceutical Division Revenue by Segment (%), 2013 Figure 7-10: Novartis – Revenue Breakup by Business Segment (%), 2013 Figure 7-11: AstraZeneca – Revenue Breakup by Therapy Area (%), 2013 Figure 7-12: Baxter International – Revenue Breakup by Business Segment (%), 2013 Figure 7-13: BioCSL – Revenue Breakup by Business Segment (%), 2013 Figure 7-14: Takeda Pharmaceutical – Revenue Breakup by Business Segment (%), 2013 Figure 7-15: Crucell – Revenue Breakup by Vaccine Type (%), 2010 List of Tables: Table 4-1: Pneumococcal Vaccine Market – Key Players and Vaccines Table 4-2: Key Pneumococcal Vaccines in Pipeline Table 4-3: Influenza Vaccine Market – Key Players and Vaccines Table 4-4: Key Influenza Vaccines in Pipeline Table 4-5: Global – Cancer Statistics in More Developed and Less Developed Regions (2008) Table 4-6: Cancer Vaccine Market – Key Players and Vaccines Table 4-7: Key Cancer Vaccines in Pipeline Table 4-8: Polio Vaccine Market – Key Players and Vaccines Table 4-9: Key Polio Vaccines in Pipeline Table 4-10: Varicella Vaccine Market – Key Players and Vaccines Table 4-11: Rotavirus Vaccine Market – Key Players and Vaccines Table 4-12: Key Rotavirus Vaccines in Pipeline Table 4-13: Meningococcal Vaccine Market – Key Players and Vaccines Table 4-14: Key Meningococcal Vaccines in Pipeline Table 4-15: DTP Vaccine Market – Key Players and Vaccines Table 4-16: Key DTP Vaccines in Pipeline Table 4-17: Hepatitis Vaccine Market – Key Players and Vaccines Table 4-18: Key Hepatitis Vaccines in Pipeline Table 4-19: MMR Vaccine Market – Key Players and Vaccines Table 4-20: Key MMR Vaccines in Pipeline Table 4-21: Japanese Encephalitis Vaccine Market – Key Players and Vaccines Table 4-22: Key Japanese Encephalitis Vaccines in Pipeline Table 4-23: Tuberculosis Vaccine Market – Key Players and Vaccines Table 4-24: Key Tuberculosis Vaccines in Pipeline Table 4-25: Key Malaria Vaccines in Pipeline Table 4-26: Rabies Vaccine Market – Key Players and Vaccines Table 4-27: Key Rabies Vaccines in Pipeline Table 4-28: Typhoid Vaccine Market – Key Players and Vaccines Table 4-29: Key Typhoid Vaccines in Pipeline Table 4-30: Global – Number of HIV/AIDS Patients by Region (2009) Table 4-31: Key HIV Vaccines in Pipeline Table 5-1: China – Vaccine Classification Table 6-1: Vaccine Pipeline Analysis Table 7-1: GSK – Vaccines Portfolio Table 7-2: GSK – Vaccines in Pipeline Table 7-3: GSK – Strengths and Weaknesses Table 7-4: Sanofi-Pasteur – Vaccines Portfolio Table 7-5: Sanofi-Pasteur – Vaccines in Pipeline Table 7-6: Sanofi-Pasteur – Strengths and Weaknesses Table 7-7: Pfizer – Vaccines Portfolio Table 7-8: Pfizer – Vaccines in Pipeline Table 7-9: Pfizer – Strengths and Weaknesses Table 7-10: Merck – Vaccines Portfolio Table 7-11: Merck – Vaccines in Pipeline Table 7-12: Merck – Strengths and Weaknesses Table 7-13: Novartis – Vaccines Portfolio Table 7-14: Novartis – Vaccines in Pipeline Table 7-15: Novartis – Strengths and Weaknesses Table 7-16: Emergent Biosolutions – Vaccines Portfolio Table 7-17: Emergent Biosolutions – Vaccines in Pipeline Table 7-18: Emergent Biosolutions – Strengths and Weaknesses Table 7-19: AstraZeneca – Vaccines Portfolio Table 7-20: AstraZeneca – Vaccines in Pipeline Table 7-21: AstraZeneca – Strengths and Weaknesses Table 7-22: Baxter International – Vaccines Portfolio Table 7-23: Baxter International – Vaccines in Pipeline Table 7-24: Baxter International – Strengths and Weaknesses Table 7-25: BioCSL – Vaccines Portfolio Table 7-26: BioCSL – Strengths and Weaknesses Table 7-27: Dendreon Corporation – Vaccines Portfolio Table 7-28: Dendreon Corporation – Vaccines in Pipeline Table 7-29: Dendreon Corporation – Strengths and Weaknesses Table 7-30: Takeda Pharmaceutical – Vaccines Portfolio Table 7-31: Takeda Pharmaceutical – Vaccines in Pipeline Table 7-32: Takeda Pharmaceutical – Strengths and Weaknesses Table 7-33: Crucell – Vaccines Portfolio Table 7-34: Crucell – Vaccines in Pipeline Table 7-35: Crucell – Strengths and Weaknesses


【レポート販売概要】

■ タイトル:グローバルワクチン市場動向(~2020)
■ 英文:Global Vaccine Market Outlook 2020
■ 発行日:2014年5月
■ 調査会社:RNCOS
■ 商品コード:RNCOS-405238
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。